SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMF)
Clinical trial NCT06990412 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. start date: 2025-05-20 → 2025-05-28 3. completion date: 2026-05-20 → 2026-01-10 4. primary completion date: 2025-12-31 → 2025-11-06 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical